首页> 外文会议>American Peptide Symposium >Design, Synthesis and Pharmacological Characterization of Fluorescein-Derived Endothelin Antagonists Bq-123 And Bq-788
【24h】

Design, Synthesis and Pharmacological Characterization of Fluorescein-Derived Endothelin Antagonists Bq-123 And Bq-788

机译:荧光素衍生的内皮素拮抗剂BQ-123和BQ-788的设计,合成和药理表征

获取原文

摘要

Endothelin-1 (ET-1) is a 21 amino acid peptide involved in the cardiovascular system. ET-1 binds to two G-protein coupled receptors namely, endothelin receptor A (ET_A) and endothelin receptor B (ET_B). Our goal is to develop fluorescent ET_A and ET_B analogues towards the study of the ET system in situ (in vivo imaging). To date, there is no published data on fluorescent and selective probe for those receptors. We design a strategy to generate FITC-derivative (fluorescein isothiocyanate-derivative) of the known BQ-123 cyclo(Pro-D-Val-Leu-D-Trp-D-Asp) and BQ-788 (N-(cis-2,6-dimethylpiperidinocarbonyl-y-methylleucyl-D-l-(methoxycarbonyl)-tryptophanyl-D-norleucine), two potent and selective antagonists for ET_A and ET_B, respectively. We also provide an in vitro pharmacological profile for each new compound.
机译:内皮素-1(ET-1)是涉及心血管系统的21个氨基酸肽。 ET-1与两个G蛋白偶联受体结合,内皮素受体A(Et_A)和内皮素受体B(ET_B)。我们的目标是开发荧光Et_A和ET_B类似物以原位(体内成像)的研究。迄今为止,对这些受体没有关于荧光和选择性探针的公开数据。我们设计了一种生成FITC-衍生物(荧光素异硫氰酸酯 - 衍生物)的策略(PRO-D-VAL-LEU-D-TRP-D-ASP)和BQ-788(N-(CIS-2 ,6-二甲基哌啶羰基酰基-Y-甲基氨基羰基(甲氧基羰基) - 三苯甲基-D-NOLLEUSUCHINCE,分别为ET_A和ET_B的两个有效和选择性拮抗剂。我们还为每种新化合物提供体外药理学曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号